Back
Vir Biotechnology Vs. Arbutus Biopharma Industry Stock Comparison
Sell
19
VIR
Vir Biotechnology
Last Price:
8.64
Seasonality Move:
40.05%
Sell
41
ABUS
Arbutus Biopharma
Last Price:
3.63
Seasonality Move:
13.65%
Sell
19
Vir Biotechnology (VIR)
is a Sell
Is Vir Biotechnology a Buy, Sell or Hold?
- The current Vir Biotechnology [VIR] share price is $8.98. The Score for VIR is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- VIR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
41
Arbutus Biopharma (ABUS)
is a Sell
Is Arbutus Biopharma a Buy, Sell or Hold?
- The current Arbutus Biopharma [ABUS] share price is $3.65. The Score for ABUS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- ABUS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VIR Stock Price Chart
What is Vir Biotechnology's stock price today?
-
The Vir Biotechnology share price today is $8.98
The current trend is moderately bearish and VIR is experiencing selling pressure, which indicates risk of future bearish movement.
ABUS Stock Price Chart
What is Arbutus Biopharma's stock price today?
-
The Arbutus Biopharma share price today is $3.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.
VIR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.49 | Buy |
Relative Strength Index (14 RSI): | 55.65 | Buy |
Chaikin Money Flow: | -637561 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.31 - 9.27) | Buy |
Bollinger Bands (100): | (7.58 - 9.48) | Buy |
ABUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 36.73 | Sell |
Chaikin Money Flow: | -592634 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.77 - 4.07) | Sell |
Bollinger Bands (100): | (3.49 - 4.15) | Sell |
VIR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.58 | Sell |
20-day SMA: | 8.47 | Buy |
50-day SMA: | 7.98 | Buy |
200-day SMA: | 9.22 | Sell |
8-day EMA: | 9.26 | Sell |
20-day EMA: | 8.74 | Buy |
50-day EMA: | 8.38 | Buy |
200-day EMA: | 9.53 | Sell |
ABUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.78 | Sell |
20-day SMA: | 3.93 | Sell |
50-day SMA: | 4.02 | Sell |
200-day SMA: | 3.34 | Buy |
8-day EMA: | 3.76 | Sell |
20-day EMA: | 3.86 | Sell |
50-day EMA: | 3.89 | Sell |
200-day EMA: | 3.42 | Buy |
Vir Biotechnology Earnings Growth & VIR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and an increase next year of $0.10 per share.
Arbutus Biopharma Earnings Growth & ABUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
Vir Biotechnology Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Arbutus Biopharma Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |